Atossa Therapeutics (Germany) Performance
| YAG2 Stock | 1.22 0.02 1.67% |
Atossa Therapeutics has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.18, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Atossa Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Atossa Therapeutics is expected to be smaller as well. Atossa Therapeutics right now shows a risk of 3.3%. Please confirm Atossa Therapeutics skewness, accumulation distribution, and the relationship between the potential upside and kurtosis , to decide if Atossa Therapeutics will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Atossa Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Atossa Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 39.7 M | |
| Total Cashflows From Investing Activities | -9000.00 |
Atossa |
Atossa Therapeutics Relative Risk vs. Return Landscape
If you would invest 122.00 in Atossa Therapeutics on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Atossa Therapeutics or generate 0.0% return on investment over 90 days. Atossa Therapeutics is generating 0.0532% of daily returns and assumes 3.3008% volatility on return distribution over the 90 days horizon. Simply put, 29% of stocks are less volatile than Atossa, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Atossa Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atossa Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Atossa Therapeutics, and traders can use it to determine the average amount a Atossa Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0161
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | YAG2 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.3 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Atossa Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atossa Therapeutics by adding it to a well-diversified portfolio.
Atossa Therapeutics Fundamentals Growth
Atossa Stock prices reflect investors' perceptions of the future prospects and financial health of Atossa Therapeutics, and Atossa Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Atossa Stock performance.
| Return On Equity | -0.18 | |||
| Return On Asset | -0.11 | |||
| Current Valuation | (59.13 M) | |||
| Shares Outstanding | 126.62 M | |||
| Price To Book | 0.62 X | |||
| EBITDA | (20.5 M) | |||
| Book Value Per Share | 0.97 X | |||
| Cash Flow From Operations | (16.47 M) | |||
| Earnings Per Share | (0.16) X | |||
| Total Asset | 141.26 M | |||
About Atossa Therapeutics Performance
Assessing Atossa Therapeutics' fundamental ratios provides investors with valuable insights into Atossa Therapeutics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Atossa Therapeutics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Atossa Therapeutics performance evaluation
Checking the ongoing alerts about Atossa Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Atossa Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Atossa Therapeutics may become a speculative penny stock | |
| Atossa Therapeutics had very high historical volatility over the last 90 days | |
| Atossa Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (20.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Atossa Therapeutics generates negative cash flow from operations |
- Analyzing Atossa Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Atossa Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Atossa Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Atossa Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Atossa Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Atossa Therapeutics' stock. These opinions can provide insight into Atossa Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Atossa Stock Analysis
When running Atossa Therapeutics' price analysis, check to measure Atossa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Therapeutics is operating at the current time. Most of Atossa Therapeutics' value examination focuses on studying past and present price action to predict the probability of Atossa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Therapeutics' price. Additionally, you may evaluate how the addition of Atossa Therapeutics to your portfolios can decrease your overall portfolio volatility.